Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced financial results for the three and nine months ended September 30, 2022 and provided a business update
By Biofrontera Inc.
Published - Nov 14, 2022, 08:53 AM ET
Last Updated - Mar 29, 2024, 09:44 AM EDT
Conference call begins at 11:00 a.m. Eastern time today
WOBURN, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced financial results for the three and nine months ended September 30, 2022 and provided a business update.
Highlights from the third quarter of 2022 and subsequent weeks include the following:
Financial Highlights
